BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based VaccinesGlobeNewsWire • 04/11/22
BioNTech Presents Positive Preliminary Phase 1/2 Data for First-in-Class CAR-T Program BNT211 at AACRGlobeNewsWire • 04/11/22
BioNTech Granted Pandemic Preparedness Contract by German Federal Ministry of HealthGlobeNewsWire • 04/08/22
Pfizer/BioNTech's Second COVID-19 Vaccine Booster Provides Short-Lived Protection In Elderly, Israel Study ShowsBenzinga • 04/06/22
BioNTech SE (BNTX) CEO Ugur Sahin on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/30/22
Dow Jones Newswires: BioNTech reports soaring earnings, revenue on COVID vaccine, plans $1.5 billion in buybacksMarket Watch • 03/30/22
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate UpdateGlobeNewsWire • 03/30/22
FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older PeopleBenzinga • 03/29/22
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and OlderBusiness Wire • 03/29/22